GEP20033054B - 2,4,4-Trisubstituted-1,3-Dioxolane Antifungals - Google Patents

2,4,4-Trisubstituted-1,3-Dioxolane Antifungals

Info

Publication number
GEP20033054B
GEP20033054B GEAP19985200A GEAP1998005200A GEP20033054B GE P20033054 B GEP20033054 B GE P20033054B GE AP19985200 A GEAP19985200 A GE AP19985200A GE AP1998005200 A GEAP1998005200 A GE AP1998005200A GE P20033054 B GEP20033054 B GE P20033054B
Authority
GE
Georgia
Prior art keywords
trisubstituted
medicine
antifungals
dioxolane
essence
Prior art date
Application number
GEAP19985200A
Other languages
English (en)
Inventor
Van Der Louis Jozef E Veken
Vanden Hugo Florent A Bossche
Frank Christopher Odds
Jan Heeres
Lieven Meerpoel
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of GEP20033054B publication Critical patent/GEP20033054B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GEAP19985200A 1997-07-11 1998-07-07 2,4,4-Trisubstituted-1,3-Dioxolane Antifungals GEP20033054B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97202181 1997-07-11

Publications (1)

Publication Number Publication Date
GEP20033054B true GEP20033054B (en) 2003-08-25

Family

ID=8228553

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19985200A GEP20033054B (en) 1997-07-11 1998-07-07 2,4,4-Trisubstituted-1,3-Dioxolane Antifungals

Country Status (34)

Country Link
US (1) US6387906B1 (et)
EP (1) EP1068200B1 (et)
KR (1) KR100540460B1 (et)
AP (1) AP1379A (et)
AR (1) AR015130A1 (et)
AT (1) ATE289303T1 (et)
AU (1) AU749760B2 (et)
BG (1) BG64314B1 (et)
BR (1) BRPI9811679B8 (et)
CA (1) CA2295090C (et)
CZ (1) CZ297453B6 (et)
DE (1) DE69829082T2 (et)
DK (1) DK1068200T3 (et)
EA (1) EA002828B1 (et)
EE (1) EE04155B1 (et)
ES (1) ES2238765T3 (et)
GE (1) GEP20033054B (et)
HK (1) HK1032404A1 (et)
HR (1) HRP20000007B1 (et)
HU (1) HU225159B1 (et)
ID (1) ID23783A (et)
IL (1) IL133919A (et)
MY (1) MY118844A (et)
NO (1) NO318328B1 (et)
NZ (1) NZ501982A (et)
PL (1) PL193703B1 (et)
PT (1) PT1068200E (et)
SI (1) SI1068200T1 (et)
SK (1) SK285321B6 (et)
TR (1) TR200000154T2 (et)
TW (1) TW593312B (et)
UA (1) UA71543C2 (et)
WO (1) WO1999002523A1 (et)
ZA (1) ZA986160B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19945982A1 (de) * 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
US20040086567A1 (en) * 2002-10-30 2004-05-06 Pawan Seth Bioequivalent composition of itraconazole and a hydrophilic polymer
AU2009223833A1 (en) * 2008-03-03 2009-09-17 Stiefel Laboratories, Inc. Processes for preparing enantiomerically pure diol and dioxolane compounds
US8431699B2 (en) * 2009-02-27 2013-04-30 Vertichem Corporation Method for manufacture of 2-oxoimidazolidines
CN105777486B (zh) * 2016-03-30 2018-09-11 浙江大学宁波理工学院 一种2-[2-(2,4-二氟苯基)-2-丙烯-1-基]-1,3-丙二醇的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4619931A (en) * 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
CA1292472C (en) 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
US4788190A (en) 1986-12-24 1988-11-29 Schering Corporation 2,4,4-tri- and 2,2,4,4-tetra substituted-1,3-dioxolane antifungal, antiallergy compounds
NZ233502A (en) * 1989-06-09 1991-11-26 Janssen Pharmaceutica Nv 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions
IL103558A0 (en) 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
PL181947B1 (en) * 1994-01-24 2001-10-31 Janssen Pharmaceutica Nv Water-soluble azole-type antimycotic agents

Also Published As

Publication number Publication date
ID23783A (id) 2000-05-11
SI1068200T1 (et) 2005-08-31
IL133919A0 (en) 2001-04-30
TR200000154T2 (tr) 2000-06-21
EA200000116A1 (ru) 2000-08-28
MY118844A (en) 2005-01-31
CA2295090C (en) 2009-09-08
HRP20000007B1 (en) 2008-12-31
CA2295090A1 (en) 1999-01-21
HUP0004459A2 (hu) 2002-04-29
DK1068200T3 (da) 2005-06-20
ES2238765T3 (es) 2005-09-01
WO1999002523A1 (en) 1999-01-21
TW593312B (en) 2004-06-21
AR015130A1 (es) 2001-04-18
HUP0004459A3 (en) 2002-11-28
AP1379A (en) 2005-03-29
PL193703B1 (pl) 2007-03-30
EE200000020A (et) 2000-10-16
AU8857698A (en) 1999-02-08
NO318328B1 (no) 2005-03-07
CZ463799A3 (cs) 2000-04-12
EA002828B1 (ru) 2002-10-31
NO20000114L (no) 2000-03-13
US6387906B1 (en) 2002-05-14
IL133919A (en) 2002-02-10
UA71543C2 (uk) 2004-12-15
CZ297453B6 (cs) 2006-12-13
EP1068200B1 (en) 2005-02-16
ATE289303T1 (de) 2005-03-15
PT1068200E (pt) 2005-07-29
SK285321B6 (sk) 2006-11-03
NZ501982A (en) 2000-10-27
BRPI9811679B8 (pt) 2021-05-25
KR100540460B1 (ko) 2006-01-12
NO20000114D0 (no) 2000-01-10
BG103982A (en) 2000-08-31
BR9811679A (pt) 2000-09-19
PL338009A1 (en) 2000-09-25
BRPI9811679B1 (pt) 2016-10-18
HK1032404A1 (en) 2001-07-20
DE69829082D1 (de) 2005-03-24
EP1068200A1 (en) 2001-01-17
HU225159B1 (en) 2006-07-28
HRP20000007A2 (en) 2000-12-31
SK184199A3 (en) 2000-07-11
BG64314B1 (bg) 2004-09-30
AP2000001730A0 (en) 2000-03-31
EE04155B1 (et) 2003-10-15
DE69829082T2 (de) 2005-12-29
AU749760B2 (en) 2002-07-04
KR20010020576A (ko) 2001-03-15
ZA986160B (en) 2000-01-10

Similar Documents

Publication Publication Date Title
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
GEP20033116B (en) New Esters Derived From Substituted Phenyl-Cyclohexyl Compounds, Methods for Their Production for Preparation Drug with Analgesic Properties
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
CA2183972A1 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
GB9914486D0 (en) Medicaments
WO2005056524A3 (en) Therapeutic agents useful for treating pain
ES8506616A1 (es) Un procedimiento para la preparacion de carboxamidas
AU4258101A (en) Combination therapies with vascular damaging activity
FI961169A0 (fi) Kiteinen vedetön mykofenolaattimofetiili ja sen intravenoosivalmiste
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
GEP20043162B (en) Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
HUT70531A (en) Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
GEP19991872B (en) Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same
HU9802897D0 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
GEP20033054B (en) 2,4,4-Trisubstituted-1,3-Dioxolane Antifungals
ATE363909T1 (de) Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
CA2133186A1 (en) 3- or 4-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
MX9600165A (es) 3-alcoxicarbonil-tiadiazinonas, proceso para su preparacion y composiciones farmaceuticas que las contienen.